<DOC>
	<DOCNO>NCT01178034</DOCNO>
	<brief_summary>Initiation warfarin therapy problematic . The investigator goal evaluate new demographic/pharmacogenetic algorithm well usual algorithm base INR value day five four day 5 mg/day warfarin . To end patient atrial fibrillation start warfarin randomize two arm .</brief_summary>
	<brief_title>Early Identification Warfarin Maintenance Dosage</brief_title>
	<detailed_description>The objective randomized study evaluate accuracy new demographic/pharmacogenetic compare usual warfarin dose algorithm predict warfarin maintenance dose . In patient atrial fibrillation start anticoagulation , load dose warfarin test group calculate basis VKORC1 genotype patient 's body weight.The second day warfarin maintenance dose calculate basis surface area CYP2C9 , CYP4F2 e VKORC1 genotype . In usual care group maintenance dose day 5 calculate basis publish algorithm ( Pengo V , Am J Cardiol 2001 ) . INR check day 0 , 5 , 7 , 9 , 12 , 15 19 . Primary end-point trial number INR outside therapeutic range 2.0 3.0 . Secondary end-points number change dose prescription , difference predict actual warfarin maintenance dose thrombotic bleeding event .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Age &gt; 18 year Indication warfarin INR 2.0 3.0 Pregnancy Drug interaction Basal INR &gt; 1.2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Warfarin</keyword>
	<keyword>Dose</keyword>
	<keyword>Pharmacogenetic</keyword>
	<keyword>INR</keyword>
</DOC>